Synergistic Effect of EZH2 Knockdown and Irradiation Against Pancreatic Cancer Cells

被引：0
|
作者：
Gupta, Raavi
Agrawal, Raag
Martello-Rooney, Laura
Haseeb, M.
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] SUNY Downstate, Brooklyn, NY USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1831
引用
收藏
页码：457A / 457A
页数：1
相关论文
共 50 条
  • [21] Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer
    Gharpure, Kshipra M.
    Chu, Kevin S.
    Bowerman, Charles J.
    Miyake, Takahito
    Pradeep, Sunila
    Mangala, Selanere L.
    Han, Hee-Dong
    Rupaimoole, Rajesha
    Armaiz-Pena, Guillermo N.
    Rahhal, Tojan B.
    Wu, Sherry Y.
    Luft, J. Christopher
    Napier, Mary E.
    Lopez-Berestein, Gabriel
    DeSimone, Joseph M.
    Sood, Anil K.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (07) : 1750 - 1757
  • [22] Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer
    Gharpure, Kshipra M.
    Chu, Kevin S.
    Bowerman, Charles
    Miyake, Takahito
    Pradeep, Sunila
    Mangala, Lingegowda S.
    Han, Hee-Dong
    Rupaimoole, Rajesha
    Wu, Sherry Y.
    Dalton, Heather J.
    Napier, Mary E.
    Lopez-Berestein, Gabriel
    DeSimone, Joseph M.
    Sood, Anil K.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] EZH2 promotes proliferation and invasiveness of prostate cancer cells
    Bryant, R. J.
    Cross, N. A.
    Eaton, C. L.
    Hamdy, F. C.
    Cunliffe, V. T.
    PROSTATE, 2007, 67 (05) : 547 - 556
  • [24] EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
    Fussbroich, Bettina
    Wagener, Nina
    Macher-Goeppinger, Stephan
    Benner, Axel
    Faelth, Maria
    Sueltmann, Holger
    Holzer, Angela
    Hoppe-Seyler, Karin
    Hoppe-Seyler, Felix
    PLOS ONE, 2011, 6 (07):
  • [25] Role of EZH2 in invasion and metastasis of colon cancer cells
    Fan, Liqing
    Jiang, Shunshun
    Wang, Yan
    Zheng, Yinglan
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 182 - 182
  • [26] EZH2 knockdown suppresses the growth of human inflammatory breast cancer cells both in vitro and in vivo in xenograft models
    Mu, Zhaomei
    Li, Hua
    Zhang, Rugang
    Cristofanilli, Massimo
    CANCER RESEARCH, 2012, 72
  • [27] The EZH2 epigenetic factor orchestrates oncogenic properties in ATMdeficient pancreatic cancer
    Roger, Elodie
    Harle, Anna
    Gout, Johann
    Perkhofer, Lukas
    Hessmann, Elisabeth
    Kleger, Alexander
    CANCER RESEARCH, 2024, 84 (02)
  • [28] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [29] Regulation and Role of EZH2 in Cancer
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    CANCER RESEARCH AND TREATMENT, 2014, 46 (03): : 209 - 222
  • [30] Functional Characterization of EZH2β, a Newly Identified Epigenetic Oncogene for Pancreatic Cancer
    Grzenda, A.
    Lomberk, G.
    Svingen, P.
    Mathison, A.
    Calvo, E.
    Iovanna, J.
    Xiong, Y.
    Faubion, W.
    Urrutia, R.
    PANCREAS, 2012, 41 (08) : 1361 - 1361
12345